On Tuesday, Oneok Partners LP (NYSE:OKS)’s shares declined -1.08% to $34.86.
ONEOK Partners, L.P. (OKS) declared that it sold about 7.2 million common units totaling about $277 million through its at-the-market equity program (ATM program) in the first half of 2015.
The common units sold throughout the year and the contributions from ONEOK, Inc. to maintain its 2 percent general partner interest generated total net proceeds of about $279.7 million, which ONEOK Partners used for general partnership purposes and to repay amounts outstanding under its commercial paper program.
ONEOK Partners sold about 1.7 million units under the ATM program during the first quarter 2015. As of June 30, 2015, ONEOK Partners had about $237.6 million of registered common units accessible to issue through its $650 million ATM program.
As of June 30, 2015, the aggregate ownership interest in the partnership held by ONEOK, Inc. and a partner, which is the sole general partner of ONEOK Partners, was about 36.8 percent, contrast with 37.6 percent as of March 31, 2015.
ONEOK Partners, L.P. engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates in three segments: Natural Gas Gathering and Processing; Natural Gas Liquids; and Natural Gas Pipelines. The Natural Gas Gathering and Processing segment gathers and processes natural gas produced from crude oil and natural gas wells located in the Mid-Continent region; and gathers and processes natural gas in the Williston Basin, which spans portions of Montana and North Dakota, and the Powder River Basin of Wyoming.
The Medicines Company (NASDAQ:MDCO)’s shares gained 1.75% to $33.73.
The Medicines Company (MDCO) has planned its quarterly conference call for Wednesday, July 29th at 8:30 a.m. Eastern Time to talk about second quarter financial results, operational developments and outlook for 2015.
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
At the end of Tuesday’s trade, LinkedIn Corp (NYSE:LNKD)‘s shares surged 0.26% to $0.00170.
LinkedIn Corp (LNKD) the world’s largest professional network on the Internet, declared that it will host a conference call to talk about its second quarter 2015 business results and outlook on Thursday, July 30th, 2015, at 2:00 p.m. Pacific Time, following the release of the Company’s business results. Jeff Weiner, CEO, and Steve Sordello, CFO, will host the call.
LinkedIn Corporation, together with its auxiliaries, operates an online professional network worldwide. The company, through its proprietary platform, allows members to create, manage, and share their professional identity online; build and engage with their professional networks; access shared knowledge and insights; and find business opportunities.
Abraxas Petroleum Corp. (NASDAQ:AXAS), ended its Tuesday’s trading session with 1.53% gain, and closed at $2.66.
Abraxas Petroleum Corporation (AXAS) will host its second quarter 2015 earnings conference call on Thursday, August 6, 2015 at 10 AM Central Time (11 AM Eastern Time). Abraxas plans to declare second quarter 2015 operating and financial results preceding to the call.
Abraxas Petroleum Corporation, an independent energy company, engages in the acquisition, exploitation, development, and production of oil and gas properties in the United States. The company operates oil and gas assets in the Rocky Mountain, Permian Basin, and onshore Gulf Coast regions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
